This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Related letters  • Similar articles in this journal  Topic Collections  • Lipids and Lipid Disorders  • Nutritional and Metabolic Disorders, Other  • Cardiovascular System  • Evidence-Based Medicine  • Cardiovascular Disease/ Myocardial Infarction  • Drug Therapy, Other  • Diabetes Mellitus  • Hypertension  • Alert me on articles by topic  Social Bookmarking   What's this?

Sarfraz Zaidi, MD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In his article, Dr Havas¹ recommends to ignore hyperglycemia in patients with type 2 diabetes mellitus until it becomes symptomatic, and even then he allows the use of metformin only, in addition to diet and exercise. I strongly disagree with his recommendations. I would like to ask Dr Havas if he would prescribe any medicine if a patient has a fasting blood glucose level between 250 and 300 mg/dL (to convert to millimoles per liter, multiply by 0.0555) while following a regimen of diet, exercise, and metformin therapy but is asymptomatic? Roughly what percentage of his patients with diabetes adhere to weight loss and exercise? For how long has he put his strategy into practice, and what kind of results is he seeing on the complications of diabetes in his patients?

I find the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial interesting. To me, the . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

The ACCORD Trial and Control of Blood Glucose Level in Type 2 Diabetes Mellitus: Time to Challenge Conventional Wisdom
Stephen Havas
Arch Intern Med. 2009;169(2):150-154.
EXTRACT | FULL TEXT  

RELATED LETTERS

Changing the Diabetes Treatment Paradigm
Ronald Hirsch
Arch Intern Med. 2009;169(13):1246.
EXTRACT | FULL TEXT  

Treatment of Type 2 Diabetes: One Extreme to Another—Reply
Stephen Havas
Arch Intern Med. 2009;169(13):1247.
EXTRACT | FULL TEXT